Moreover, mitochondrial cytochrome P450 2E1 (CYP2E1), which is a potential direct source of ROS, has been demonstrated to have an increased activity in an animal model of NASH and also in NASH patients [35, 36]. This evidence concerns the gene CYP2E1 and metabolic dysfunction-associated steatohepatitis.